Imatinib Recruiting Phase N/A Trials for Chronic Myelogenous Leukemia (CML) Treatment

IndicationsStatusPurposePhase
RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01316250Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia